Because I promised my granddaughter more days like this.

Our commitment starts here.
Find. Fight. Follow.

Because better insights mean better decision-making.

Our commitment starts here.
Find. Fight. Follow.

Because their lives are in our hands.

Our commitment starts here.
Find. Fight. Follow.

$0.00
+
| (Common Stock)

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Visit Investor Site

For more than half a century, our diagnostic and therapeutic innovations have changed the way clinicians Find, Fight and Follow® disease. Today, we go further still—with the same sense of purpose and commitment to empowering healthcare professionals with life-changing science that helps improve outcomes and lives.

Our History

News & Media

09/13/22

GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

Phase III clinical trial of [ 18 F]flurpiridaz PET diagnostic radiopharmaceutical meets co-primary endpoints for detecting Coronary Artery Disease (CAD) Trial also met its first key secondary endpoint, demonstrating higher diagnostic efficacy for [ 18 F]flurpiridaz PET compared to SPECT Myocardial

Read More
09/01/22

Lantheus to Present at the Wells Fargo Healthcare Conference

NORTH BILLERICA, Mass. , Sept. 01, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative diagnostics, targeted therapeutics and artificial intelligence solutions that empower clinicians to Find,

Read More
08/04/22

Lantheus Reports Second Quarter 2022 Financial Results

Worldwide revenue of $223.7 million for the second quarter 2022, representing an increase of 121.4% from the prior year period GAAP net income of $43.1 million for the second quarter 2022, compared to GAAP net loss of $26.7 million in the prior year period GAAP fully diluted net income per share of

Read More
07/21/22

Lantheus Holdings to Host Second Quarter 2022 Earnings Conference Call and Webcast on August 4, 2022, at 8:00 a.m. Eastern Time

NORTH BILLERICA, Mass. , July 21, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 4, 2022 , to discuss its financial and operating results for the second quarter of

Read More